Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Research Award - Ethics, Law and Society

University of Toronto

$66,000.00

Commercialization and Controversy: The Case of Stem Cell Innovation

FY 2008-09

Summary
Stem cell research has been subject to considerable ethical scrutiny because of the use of embryos for scientific purposes. At the same time, stem cell researchers, funders and patient organizations confront elevated expectations of scientific and therapeutic promise. These researchers concerned with moving basic discoveries further downstream toward usable products, and those professionals who work to 'transfer' technology to market (i.e., technology transfer professionals) must manage commercialization imperatives in a climate of unprecedented levels of ethical oversight and regulation. This research will use qualitative research methods, including interviews and fieldwork observation, to explore how these multiple pressures are experienced by those involved in stem cell research and commercialization. Of particular interest are tensions that may be experienced in the use of human embryonic stem cells relative to stem cells drawn from non-embryonic sources. Examining the beliefs, motivations and perceived roles and responsibilities of individuals directly involved in stem cell research and translation will shed light on how the controversial nature of the field in which they work affects their individual perceptions and decisions. This research will produce an in-depth account of imperatives to commercialize research in the face of controversy, and aim towards the production of policy guidance in Canada and internationally (e.g., OECD, WHO) on improving the responsiveness of innovation efforts to health and health system concerns.
Program
Doctoral Research Award - Ethics, Law and Society
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
178033
Name
Axler Renata E
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Health systems / services
Prcname2
Doctoral Research Awards - B
Projecttitle
Commercialization and Controversy: The Case of Stem Cell Innovation
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$66,000
Cihrequipment2
$0
Programname2
Doctoral Research Award - Ethics, Law and Society
Keyworddelim
Bioethics; Health Policy; Patents; Qualitative Research; Research Commercialization; Research Ethics; Research Regulation; Science And Technology Studies; Sociology Of Science; Stem Cell Research
Abstract
Stem cell research has been subject to considerable ethical scrutiny because of the use of embryos for scientific purposes. At the same time, stem cell researchers, funders and patient organizations confront elevated expectations of scientific and therapeutic promise. These researchers concerned with moving basic discoveries further downstream toward usable products, and those professionals who work to 'transfer' technology to market (i.e., technology transfer professionals) must manage commercialization imperatives in a climate of unprecedented levels of ethical oversight and regulation. This research will use qualitative research methods, including interviews and fieldwork observation, to explore how these multiple pressures are experienced by those involved in stem cell research and commercialization. Of particular interest are tensions that may be experienced in the use of human embryonic stem cells relative to stem cells drawn from non-embryonic sources. Examining the beliefs, motivations and perceived roles and responsibilities of individuals directly involved in stem cell research and translation will shed light on how the controversial nature of the field in which they work affects their individual perceptions and decisions. This research will produce an in-depth account of imperatives to commercialize research in the face of controversy, and aim towards the production of policy guidance in Canada and internationally (e.g., OECD, WHO) on improving the responsiveness of innovation efforts to health and health system concerns.
Competitiondate
200810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Axler, Renata E
Approvedterm
3 ans 0 mois
Cihrcontribution2
Institute of Genetics~ $66,000~ $0~